Vycor Medical Stock Revenue
| VYCO Stock | USD 0.07 0 1.47% |
Vycor Medical fundamentals help investors to digest information that contributes to Vycor Medical's financial success or failures. It also enables traders to predict the movement of Vycor OTC Stock. The fundamental analysis module provides a way to measure Vycor Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vycor Medical otc stock.
Vycor |
Vycor Medical OTC Stock Revenue Analysis
Vycor Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Vycor Medical Revenue | 1.39 M |
Most of Vycor Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vycor Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Vycor Medical reported 1.39 M of revenue. This is 99.98% lower than that of the Health Care Equipment & Supplies sector and 99.95% lower than that of the Health Care industry. The revenue for all United States stocks is 99.99% higher than that of the company.
Vycor Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vycor Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Vycor Medical could also be used in its relative valuation, which is a method of valuing Vycor Medical by comparing valuation metrics of similar companies.Vycor Medical is currently under evaluation in revenue category among its peers.
Vycor Fundamentals
| Return On Asset | -0.24 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.31) % | |||
| Current Valuation | 4.17 M | |||
| Shares Outstanding | 32.53 M | |||
| Shares Owned By Insiders | 64.50 % | |||
| Price To Earning | (2.74) X | |||
| Price To Sales | 2.60 X | |||
| Revenue | 1.39 M | |||
| Gross Profit | 1.26 M | |||
| EBITDA | (252.02 K) | |||
| Net Income | (435.66 K) | |||
| Cash And Equivalents | 43.62 K | |||
| Total Debt | 150 K | |||
| Debt To Equity | 390.90 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | (0.09) X | |||
| Cash Flow From Operations | 21.37 K | |||
| Earnings Per Share | (0.02) X | |||
| Beta | 1.31 | |||
| Market Capitalization | 3.03 M | |||
| Total Asset | 935.36 K | |||
| Retained Earnings | (24.68 M) | |||
| Working Capital | (584 K) | |||
| Current Asset | 559 K | |||
| Current Liabilities | 1.14 M | |||
| Z Score | -23.4 | |||
| Net Asset | 935.36 K |
About Vycor Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vycor Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vycor Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vycor Medical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Vycor Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vycor Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vycor Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Vycor OTC Stock
| 0.48 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
The ability to find closely correlated positions to Vycor Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vycor Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vycor Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vycor Medical to buy it.
The correlation of Vycor Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vycor Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vycor Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vycor Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.